PhD Candidate
University of Alberta, Canada
Mohammad Nasrullah is a PhD candidate at the Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta. His research is centered on developing lipopolymer-based delivery systems for targeted RNA interference therapies against leukemia. Specifically, he utilizes lipid-substituted polyethylenimine to deliver therapeutic siRNAs (LPNPs), aiming to inhibit the growth of lymphoblastic and myeloid leukemias in preclinical models by targeting oncogenes.